74 related articles for article (PubMed ID: 1888137)
1. Induction of morphological transformation, anchorage-independent growth and plasminogen activators in non-tumorigenic human osteosarcoma cells by lead chromate.
Sidhu MK; Fernandez C; Khan MY; Kumar S
Anticancer Res; 1991; 11(3):1045-53. PubMed ID: 1888137
[TBL] [Abstract][Full Text] [Related]
2. Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particles.
Patierno SR; Banh D; Landolph JR
Cancer Res; 1988 Sep; 48(18):5280-8. PubMed ID: 3409252
[TBL] [Abstract][Full Text] [Related]
3. Transformation of non-tumorigenic osteoblast-like human osteosarcoma cells by hexavalent chromates: alteration of morphology, induction of anchorage-independence and proteolytic function.
Rani AS; Kumar S
Carcinogenesis; 1992 Nov; 13(11):2021-7. PubMed ID: 1423871
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and secretion of plasminogen activators and plasminogen activator inhibitors in cell lines of different groups of human lung tumors.
Heidtmann HH; Hofmann M; Jacob E; Erbil C; Havemann K; Schwartz-Albiez R
Cancer Res; 1989 Dec; 49(24 Pt 1):6960-5. PubMed ID: 2555056
[TBL] [Abstract][Full Text] [Related]
5. [Antisense inhibition of urokinase in a human osteosarcoma cell line].
Haeckel C; Krueger S; Roessner A
Verh Dtsch Ges Pathol; 1998; 82():170-7. PubMed ID: 10095429
[TBL] [Abstract][Full Text] [Related]
6. Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts.
Biedermann KA; Landolph JR
Cancer Res; 1987 Jul; 47(14):3815-23. PubMed ID: 3594439
[TBL] [Abstract][Full Text] [Related]
7. Neoplastic transformation of human cells in vitro.
Rhim JS
Crit Rev Oncog; 1993; 4(3):313-35. PubMed ID: 8485202
[TBL] [Abstract][Full Text] [Related]
8. Metastasis of human colon tumor cells in vivo: correlation with the overexpression of plasminogen activators and 72 kDa gelatinase.
Shah V; Kumar S; Zirvi KA
In Vivo; 1994; 8(3):321-6. PubMed ID: 7803712
[TBL] [Abstract][Full Text] [Related]
9. Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix.
Niedbala MJ; Sartorelli AC
Cancer Res; 1989 Jun; 49(12):3302-9. PubMed ID: 2497975
[TBL] [Abstract][Full Text] [Related]
10. Integrin alpha 2 beta 1 in tumorigenic human osteosarcoma cell lines regulates cell adhesion, migration, and invasion by interaction with type I collagen.
Vihinen P; Riikonen T; Laine A; Heino J
Cell Growth Differ; 1996 Apr; 7(4):439-47. PubMed ID: 9052985
[TBL] [Abstract][Full Text] [Related]
11. Expression of neoplasia-related proteins of chemically transformed HuT fibroblasts in human osteosarcoma HOS fibroblasts and modulation of actin expression upon elevation of tumorigenic potential.
Goldstein D; Leavitt J
Cancer Res; 1985 Jul; 45(7):3256-61. PubMed ID: 3859366
[TBL] [Abstract][Full Text] [Related]
12. Transformation of immortal, non-tumorigenic osteoblast-like human osteosarcoma cells to the tumorigenic phenotype by nickel sulfate.
Rani AS; Qu DQ; Sidhu MK; Panagakos F; Shah V; Klein KM; Brown N; Pathak S; Kumar S
Carcinogenesis; 1993 May; 14(5):947-53. PubMed ID: 8504488
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate.
Gross JL; Behrens DL; Mullins DE; Kornblith PL; Dexter DL
Cancer Res; 1988 Jan; 48(2):291-6. PubMed ID: 3121170
[TBL] [Abstract][Full Text] [Related]
14. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
[TBL] [Abstract][Full Text] [Related]
15. Partial transformation of human tumor cell lines showing defective interaction between unusual p53 gene product and SV40 large-T antigen.
Van Roy F; Liebaut G; Mareel M; Fiers W
Oncogene; 1990 Feb; 5(2):207-18. PubMed ID: 2157184
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line.
Karikó K; Kuo A; Boyd D; Okada SS; Cines DB; Barnathan ES
Cancer Res; 1993 Jul; 53(13):3109-17. PubMed ID: 8391387
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activators in nude mice xenotransplanted with human tumorigenic cells.
Colombi M; Bellotti D; De Petro G; Barlati S
Invasion Metastasis; 1995; 15(1-2):22-33. PubMed ID: 7672929
[TBL] [Abstract][Full Text] [Related]
19. Relationship between circulating plasminogen activators and tumor development in mice.
Colombi M; Rebessi L; Boiocchi M; Barlati S
Cancer Res; 1986 Nov; 46(11):5748-53. PubMed ID: 3093069
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor stimulates proliferation of human osteosarcoma cells and accumulation of c-myc messenger RNA.
Kirstein M; Baglioni C
J Cell Physiol; 1988 Mar; 134(3):479-84. PubMed ID: 2450880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
